Published in Diabetes Metab on March 17, 2009
Insulin-like growth factor axis and risk of type 2 diabetes in women. Diabetes (2012) 1.08
Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinol Metab Clin North Am (2012) 1.02
Insulin-like growth factor-1 deficiency and metabolic syndrome. J Transl Med (2016) 0.90
RTEF-1 attenuates blood glucose levels by regulating insulin-like growth factor binding protein-1 in the endothelium. Circ Res (2012) 0.87
Evaluation of IGFBP-7 DNA methylation changes and serum protein variation in Swedish subjects with and without type 2 diabetes. Clin Epigenetics (2013) 0.87
Increased DNA methylation levels of the insulin-like growth factor binding protein 1 gene are associated with type 2 diabetes in Swedish men. Clin Epigenetics (2013) 0.86
IGF-binding protein 1 and abdominal obesity in the development of type 2 diabetes in women. Eur J Endocrinol (2010) 0.86
Primary hyperparathyroidism and metabolic risk factors, impact of parathyroidectomy and vitamin D supplementation, and results of a randomized double-blind study. Eur J Endocrinol (2013) 0.81
Epigenetic analyses of the insulin-like growth factor binding protein 1 gene in type 1 diabetes and diabetic nephropathy. Clin Epigenetics (2014) 0.80
The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus. J Clin Med (2014) 0.79
Association of tamoxifen use and increased diabetes among Asian women diagnosed with breast cancer. Br J Cancer (2014) 0.76
Antidiabetic and Hypolipidemic Activities of Curculigo latifolia Fruit:Root Extract in High Fat Fed Diet and Low Dose STZ Induced Diabetic Rats. Evid Based Complement Alternat Med (2013) 0.75
Potential diagnostic biomarkers for chronic kidney disease of unknown etiology (CKDu) in Sri Lanka: a pilot study. BMC Nephrol (2017) 0.75
Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation (1998) 3.16
Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia (2006) 2.91
Red cell distribution width, haemoglobin A1c and incidence of diabetes mellitus. J Intern Med (2014) 2.85
Incidence of severe knee and hip osteoarthritis in relation to different measures of body mass: a population-based prospective cohort study. Ann Rheum Dis (2008) 2.35
Diabetes, prediabetes and cancer mortality. Diabetologia (2010) 2.22
New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). J Intern Med (2010) 2.09
Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia (2008) 1.90
Sleep as restitution: an introduction. J Intern Med (2003) 1.77
Assessing the effect of interaction between an FTO variant (rs9939609) and physical activity on obesity in 15,925 Swedish and 2,511 Finnish adults. Diabetologia (2009) 1.62
Applying the Nottingham Prognostic Index to a Swedish breast cancer population. South East Swedish Breast Cancer Study Group. Breast Cancer Res Treat (1999) 1.62
Altered properties of the fibrin gel structure in patients with IDDM. Diabetologia (1996) 1.57
Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: a cohort study of 8486 primary-care patients. Diabetes Metab (2013) 1.55
A common methylenetetrahydrofolate reductase gene mutation and longevity. Atherosclerosis (1998) 1.50
Ceruloplasmin and atrial fibrillation: evidence of causality from a population-based Mendelian randomization study. J Intern Med (2013) 1.47
Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women. Osteoporos Int (2006) 1.44
Genetic and environmental architecture of the features of the insulin-resistance syndrome. Am J Hum Genet (1997) 1.42
Are there differences of inflammatory bio-markers between diabetic and non-diabetic patients with critical limb ischemia? Int Angiol (2006) 1.41
Insulin-like growth factor binding protein-1 as glucose regulator in adolescent boys with type 1 diabetes. Acta Paediatr (2000) 1.38
Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemia. Diabetes Obes Metab (2008) 1.33
C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study. Osteoarthritis Cartilage (2008) 1.30
Association between dietary meat consumption and incident type 2 diabetes: the EPIC-InterAct study. Diabetologia (2012) 1.29
Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes. J Hum Hypertens (2007) 1.29
The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study. Diabetologia (2012) 1.28
Chronic psychosocial stress predicts long-term cardiovascular morbidity and mortality in middle-aged men. Eur Heart J (2004) 1.24
Venous function assessed during a 5 year period after acute ilio-femoral venous thrombosis treated with anticoagulation. Eur J Vasc Surg (1990) 1.22
Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort. Int J Obes (Lond) (2012) 1.21
Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance. Diabetologia (2012) 1.20
Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register. Diabetes Metab (2007) 1.15
Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population. Atherosclerosis (2005) 1.13
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. Diabetologia (2011) 1.13
Genetic influences of the intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in development of Type 1 diabetes and diabetic nephropathy. Diabet Med (2006) 1.11
Efficacy and tolerability of vildagliptin in drug-naïve patients with type 2 diabetes and mild hyperglycaemia*. Diabetes Obes Metab (2007) 1.11
Weight change and mortality: the Nord-Trøndelag Health Study. J Intern Med (2005) 1.11
Age-specific direct healthcare costs attributable to diabetes in a Swedish population: a register-based analysis. Diabet Med (2008) 1.10
Microalbuminuria and risk factors in type 1 and type 2 diabetic patients. Diabetes Res Clin Pract (2005) 1.09
Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin-like growth factor. Scand J Rheumatol (2008) 1.08
In type 2 diabetes, randomisation to advice to follow a low-carbohydrate diet transiently improves glycaemic control compared with advice to follow a low-fat diet producing a similar weight loss. Diabetologia (2012) 1.07
Skin capillary circulation severely impaired in toes of patients with IDDM, with and without late diabetic complications. Diabetologia (1995) 1.06
Serum levels of insulin-like growth factor-I, IGF-binding protein 1 and 3, and insulin and endometrial cancer risk. Br J Cancer (2003) 1.05
Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers. Diabetes Care (1999) 1.04
Masked nocturnal hypertension--a novel marker of risk in type 2 diabetes. Diabetologia (2009) 1.03
Dietary fat intake and early mortality patterns--data from The Malmö Diet and Cancer Study. J Intern Med (2005) 1.03
Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of l-lactate. Wound Repair Regen (1999) 1.03
Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. J Clin Endocrinol Metab (1995) 1.03
Coenzyme Q10 prevents GDP-sensitive mitochondrial uncoupling, glomerular hyperfiltration and proteinuria in kidneys from db/db mice as a model of type 2 diabetes. Diabetologia (2012) 1.03
Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men. Diabetologia (2008) 1.02
Socio-economic characteristics and quality of life in diabetes mellitus--relation to metabolic control. Scand J Public Health (1999) 1.02
Obesity and cardiovascular risk factors in type 2 diabetes: results from the Swedish National Diabetes Register. J Intern Med (2006) 1.02
Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study. Thorax (2008) 1.01
Quantitative genetic analyses of insulin-like growth factor I (IGF-I), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins. J Clin Endocrinol Metab (1996) 1.00
Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE). Int J Clin Pract (2013) 1.00
Hepatocyte growth factor may accelerate healing in chronic leg ulcers: a pilot study. J Dermatolog Treat (2002) 1.00
Incidence and prognosis in early onset breast cancer. Breast (2002) 0.99
Insulin-like growth factor-binding protein-1 and prostate cancer. J Natl Cancer Inst (1999) 0.99
A novel blood-based biomarker for detection of autism spectrum disorders. Transl Psychiatry (2012) 0.97
Elevated intraocular levels of insulin-like growth factor I in a diabetic patient with acromegaly. Orbit (2002) 0.97
Combined seropositivity for H. pylori and C. pneumoniae is associated with age, obesity and social factors. J Cardiovasc Risk (2000) 0.95
Measurement of glucose and metabolites in subcutaneous adipose tissue during hyperglycemia with microdialysis at various perfusion flow rates. Clin Chim Acta (2005) 0.95
Short-term hypocaloric nutrition but not bed rest decrease insulin sensitivity and IGF-I bioavailability in healthy subjects: the importance of glucagon. Nutrition (1998) 0.95
Increased abdominal obesity, adverse psychosocial factors and shorter telomere length in subjects reporting early ageing; the MONICA Northern Sweden Study. Scand J Public Health (2008) 0.94
Fibroblasts derived from human chronic diabetic wounds have a decreased proliferation rate, which is recovered by the addition of heparin. J Dermatol Sci (1998) 0.92
Carotid intima-media thickness and apolipoprotein B/apolipoprotein A-I ratio in middle-aged patients with Type 2 diabetes. Diabet Med (2009) 0.92
A strong association between biologically active testosterone and leptin in non-obese men and women is lost with increasing (central) adiposity. Int J Obes Relat Metab Disord (2001) 0.91
Perioperative insulin and glucose infusion maintains normal insulin sensitivity after surgery. Am J Physiol (1998) 0.91
The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial. Diabetologia (2011) 0.91
High serum hepatocyte growth factor levels in the acute stage of community-acquired infectious diseases. Scand J Infect Dis (2002) 0.91
Risk factors for cardiovascular disease and future osteoarthritis-related arthroplasty: a population-based cohort study in men and women from Malmö, Sweden. Scand J Rheumatol (2011) 0.91
Hepatocyte growth factor levels in cerebrospinal fluid: a comparison between acute bacterial and nonbacterial meningitis. J Infect Dis (2000) 0.91
Avoidance of weight gain is important for oral type 2 diabetes treatments in Sweden and Germany: patient preferences. Diabetes Metab (2013) 0.91
Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ). Thorax (2008) 0.90
The mode of left ventricular pumping: is there an outer contour change in addition to the atrioventricular plane displacement? Clin Physiol (2001) 0.90
Pronounced skin capillary ischemia in the feet of diabetic patients with bad metabolic control. Diabetologia (1998) 0.90
Effects of 3 days of "postoperative" low caloric feeding with or without bed rest on insulin sensitivity in healthy subjects. Clin Nutr (2003) 0.90
Skin capillary circulation is more impaired in the toes of diabetic than non-diabetic patients with peripheral vascular disease. Diabet Med (1995) 0.90
Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes mellitus: increased prevalence and relation to vascular complications. Clin Exp Immunol (1999) 0.90
Insulin-like growth factor-I and insulin-like growth factor binding protein-1 in a representative population of type 2 diabetic patients in Sweden. Scand J Clin Lab Invest (1998) 0.89
Gender difference in the leptin response to feeding in peroxisome-proliferator-activated receptor-alpha knockout mice. Int J Obes Relat Metab Disord (2002) 0.89
Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR). Diabet Med (2009) 0.89
Exhaled breath condensate and serum levels of hepatocyte growth factor in pneumonia. Respir Med (2002) 0.89
Assessment of recovery after day surgery using a modified version of quality of recovery-40. Acta Anaesthesiol Scand (2009) 0.89
Associations between insulin-like growth factor-I (IGF-I), IGF-binding protein-1, insulin and other metabolic measures after controlling for genetic influences: results from middle-aged and elderly monozygotic twins. J Endocrinol (1997) 0.89
Decreased IGF-I bioavailability after ethanol abuse in alcoholics: partial restitution after short-term abstinence. J Endocrinol Invest (2001) 0.89
Acute hypoxia induces apoptosis of pancreatic β-cell by activation of the unfolded protein response and upregulation of CHOP. Cell Death Dis (2012) 0.88
Alcohol ingestion decreases both diurnal and nocturnal secretion of leptin in healthy individuals. Clin Endocrinol (Oxf) (2001) 0.87
Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men. Exp Clin Endocrinol Diabetes (2005) 0.87
Insulin-like growth factor (IGF)-1 and IGF-binding protein-1 concentrations in serum of normal subjects after alcohol ingestion: evidence for decreased IGF-1 bioavailability. Clin Endocrinol (Oxf) (2000) 0.87
Heat production, nerve function, and morphology following nerve close dissection with surgical instruments. World J Surg (2012) 0.87
Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs. Acta Med Scand (1987) 0.86
Enhanced generation of interleukins 1 beta and 6 may contribute to the cachexia of chronic disease. Am J Clin Nutr (1997) 0.86
Associations of HbA1c and educational level with risk of cardiovascular events in 32,871 drug-treated patients with Type 2 diabetes: a cohort study in primary care. Diabet Med (2013) 0.86
Treatment with low-dose prednisolone is associated with altered body composition but no difference in bone mineral density in rheumatoid arthritis patients: a controlled cross-sectional study. Scand J Rheumatol (2010) 0.85
Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment. J Am Coll Cardiol (2000) 0.85
Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex. J Clin Endocrinol Metab (1994) 0.85
CSF circulation in subjects with the empty sella syndrome. Neuroradiology (1981) 0.84
Insulin sensitivity increase after calcium supplementation and change in intraplatelet calcium and sodium-hydrogen exchange in hypertensive patients with Type 2 diabetes. Diabet Med (2009) 0.84
Responses of insulin-like growth factor (IGF)-I and IGF-binding proteins to nutritional status in peroxisome proliferator-activated receptor-alpha knockout mice. Growth Horm IGF Res (2001) 0.84
Tamoxifen-induced cell death in malignant melanoma cells: possible involvement of the insulin-like growth factor-1 (IGF-1) pathway. Mol Cell Endocrinol (2000) 0.84
Longitudinal study of the maternal insulin-like growth factor system before, during and after pregnancy in relation to fetal and infant weight. Horm Res (2007) 0.83
The association between hyperglycemia and fracture risk in middle age. A prospective, population-based study of 22,444 men and 10,902 women. J Clin Endocrinol Metab (2007) 0.83
Intraoperative dreams reported after general anaesthesia are not early interpretations of delayed awareness. Acta Anaesthesiol Scand (2008) 0.83